MICE containing human tissue are producing antibodies that could save the
lives of people with the fatal liver disease, hepatitis B. And they could also
be used to test the effectiveness of drugs against a wide range of other
diseases.
The mouse has been dubbed the ātrimeraā, because it contains tissue from
three sources: its own tissue, red blood cells from other mice, and grafts of
human tissue.
Yair Reisner at the Weizmann Institute of Science in Rehovot, Israel, created
the trimera, and it is being commercially developed by XTL Biopharmaceuticals in
Rehovot. Human antibodies produced by the trimera for treating hepatitis B are
to be tested early next year at the Hebrew University Hadassah Hospital in
Jerusalem.
Advertisement
The trimera mice are created in a three-step process. First, they are
irradiated, a process that kills off the animalsā own immune systems.
Because the radiation destroys the miceās ability to make red blood cells,
they then have to be injected with bone marrow cells from other mice. The
injected cells, taken from mice that also have weakened immune systemsāto
avoid regenerating the recipientās immune systemāmature into the missing
red blood cells, giving the trimera a fresh supply.
Finally, the mice are given human tissue. āThe mouse canāt mount an immune
response because its own immune system is damaged beyond repair,ā says Martin
Becker, the chief executive of XTL. āThis means that the mouse canāt reject
human cells that are transplanted in the final stage,ā he says.
If the mouse is given a graft of an infected human liver, for example, it can
be used to test drugs that fight that infection. But the researchers have made
most progress by injecting the trimera with human white blood cellsāto
give the mouse a complete replica of the human immune system, which will
generate human antibodies.
What makes the mouse such a powerful tool for making antibodies, says Becker,
is that the white blood cells can be derived from humans who have successfully
fought off an infection such as hepatitis B. The implanted white blood cells
have already encountered the virus, and are primed to fight it.
In the mouse, the human cells make still more antibodies. āThis mouse serves
as an amplification vehicle because it mimics the normal human immune system,ā
says Becker.
Finally, the human cells that make the antibodies are extracted from the
mouseās spleen. Each antibody can then be manufactured in large amounts through
standard cloning techniques.
Becker is confident that the trimera has the edge over other techniques. He
says, for example, that generating antibodies in the mice is more like the human
immune response than growing antibodies in a test tube.
Becker says that the trimera is also similar in many respects to the SCID
(Severe Combined Immune Deficient) mouse created a decade ago. This animal was
engineered to have a genetically disabled immune system so that it would
tolerate implants of white blood cells and other human material.
But he adds that the white blood cells function better in the trimera because
the mouse starts off with a normal immune system before it is āknocked outā by
radiation. This makes it easier for human white blood cells to take over where
the mouseās immune system left off than in SCID mice, where the immune system
never functioned.
